ScholarIQanswers from OpenAlex & ORCID
Brad H. Rovin
ResearcherPublications, citations & collaboration network
Brad H. Rovin is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Brad H. Rovin have?
ScholarIQindexed works
Brad H. Rovin has 654 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Brad H. Rovin have?
ScholarIQcitation count
Brad H. Rovin has 39,374 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Brad H. Rovin?
ScholarIQh-index
Brad H. Rovin has an h-index of 90 in OpenAlex.
What is the i10-index of Brad H. Rovin?
ScholarIQi10-index
Brad H. Rovin has an i10-index of 315 in OpenAlex.
What is the ORCID of Brad H. Rovin?
ScholarIQorcid
The ORCID for Brad H. Rovin is on the source record.
What is the OpenAlex record for Brad H. Rovin?
ScholarIQopenalex
The OpenAlex for Brad H. Rovin is on the source record.
What are the most-cited papers on Brad H. Rovin?
ScholarIQmost cited works
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Lee A. Hebert, Samir M. Parikh, Jason Prosek, Tibor Nádasdy, Brad H. Rovin
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan M. Mejía‐Vilet, Carla Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan‐Stephan Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney Tang, Vladimı́r Tesař, Marina Vivarelli, Jack F.M. Wetzels, Jürgen Floege
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
Brad H. Rovin, Richard Furie, Kevin Latinis, R. John Looney, Fernando C. Fervenza, Jorge Sánchez‐Guerrero, Romeo Maciuca, David Zhang, Jay Garg, Paul Brunetta, Gerald B. Appel, LUNAR Investigator Group
The Influence of <i>CCL3L1</i> Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility
Enrique A. González, Hemant Kulkarni, Héctor Bolívar, Andrea Mangano, Racquel Sanchez, Gabriel Catano, Robert J. B. Nibbs, Barry I. Freedman, Marlon P. Quinones, Michael J. Bamshad, Krishna K. Murthy, Brad H. Rovin, William P. Bradley, Robert A. Clark, Stephanie A. Anderson, Robert J. O’Connell, Brian K. Agan, Seema S. Ahuja, Seema S. Ahuja, Rosa Bologna, Luisa Sen, Matthew J. Dolan, Sunil K. Ahuja, Sunil K. Ahuja
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Richard Furie, Brad H. Rovin, Frédéric Houssiau, Ana Malvar, Y K Onno Teng, Gabriel Contreras, Zahir Amoura, Xueqing Yu, Chi-Chiu Mok, Mittermayer B. Santiago, Amit Saxena, Yulia Green, Beulah Ji, C. Kleoudis, Susan W. Burriss, Carly Barnett, David A. Roth